Sermonix Pharmaceuticals, Inc. — Form D
Sermonix Pharmaceuticals, Inc. of COLUMBUS, OH, a company, filed a Form D exempt-offering notice with the SEC on 2016-07-11. The offering totals $2.5M, of which $1.6M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2016-07-11
- Form: D
- Accession: 0001655566-16-000003
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $2.5M
- Amount sold: $1.6M
- Remaining: $950K
- Minimum investment: $25K
- Investors: 2
- Date of first sale: 2016-07-05
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-266691
Issuer
- Name: Sermonix Pharmaceuticals, Inc.
- CIK: 0001655566
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 3000 E. MAIN ST, COLUMBUS, OH, 43209
- Phone: (614) 864-4919
Officers, directors & promoters (17)
| Name | Role | Location |
|---|
| Miriam Portman | Director | Columbus, OH |
| Patrick Wiesel | Director | Columbus, OH |
| Simon Jenkins | Executive Officer | Vero Beach, FL |
| Michael Friedman | Director | Aventura, FL |
| Anthony Wild | Director | Columbus, OH |
| Anthony Wild | Executive Officer | Columbus, OH |
| Miriam Portman | Executive Officer | Columbus, OH |
| Miriam Portman | Promoter | Columbus, OH |
| Elizabeth Attias | Executive Officer | Columbus, OH |
| Elizabeth Garner | Director | Columbus, OH |
| David Portman | Director | Columbus, OH |
| David Portman | Executive Officer | Columbus, OH |
| David Portman | Promoter | Columbus, OH |
| Richard De Schutter | Director | Columbus, OH |
| Barry Komm | Executive Officer | Columbus, OH |
| Thomas Pfisterer | Director | Columbus, OH |
| Paul Plourde | Executive Officer | Columbus, OH |
Other filings by this issuer (2)
More